Twist Bioscience Corp (0ME.BE)
| Previous close | 43.46 |
| Open | 42.81 |
| Bid | 42.95 x 0 |
| Ask | 43.57 x 0 |
| Day's range | 42.38 - 43.26 |
| 52-week range | 11.69 - 46.22 |
| Volume | |
| Avg. volume | 5 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 02 Aug 2024 - 06 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Business WireTwist Bioscience Launches Multiplexed Gene Fragments to Enable High-throughput Screening Applications
SOUTH SAN FRANCISCO, Calif., May 13, 2024--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the launch of Twist Multiplexed Gene Fragments (MGFs), pools of directly synthesized double-stranded DNA (dsDNA) up to 500 base pairs in length with no limit on sequence number to enable high throughput screening applications.
Business WireTwist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., May 08, 2024--As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) ("Twist" or the "Company"), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has granted a total of 87,200 restricted stock units ("RSUs") to 26 recently hired individuals as an inducement material to their acceptance of employment with Twist. The employment inducem
Simply Wall St.Earnings Update: Twist Bioscience Corporation (NASDAQ:TWST) Just Reported Its Second-Quarter Results And Analysts Are Updating Their Forecasts
Twist Bioscience Corporation ( NASDAQ:TWST ) defied analyst predictions to release its second-quarter results, which...
